https://www.biospace.com/adocia-to-present-positive-clinical-results-for-biochaperone-lispro-at-the-american-diabetes-association-75th-scientific-sessions-on-june-6th-2015
clinical resultspresentpositivelispro
https://www.expertmarketresearch.com/reports/asia-pacific-biosimilar-insulin-glargine-and-lispro-market
APAC biosimilar insulin market grows with global rise. Global market to hit USD 9272.31 Million by 2035 from USD 2436.27 Million in 2025 at 14.30% CAGR.
biosimilar insulinapacglarginelispromarket